iShares Genomics Immunology and Healthcare ETF
Registrant
iShares Trust
Class ticker
Net Assets
$160,477,921
Holdings
35
Latest Report
Apr 30, 2026
Holdings · 35
Export CSV
Only this fund's positions in US-listed stocks Equibles tracks are shown. Other
holdings — bonds, foreign securities, and cash — aren't listed yet, so the positions
below are a fraction of the fund's
$160,477,921 in net assets.
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES, INC. | RVMD | 76,325 | $10,999,959 | 6.85% | Long | EC | |
| MODERNA, INC. | MRNA | 219,441 | $10,081,120 | 6.28% | Long | EC | |
| MERCK & CO., INC. | MRK | 60,956 | $6,655,176 | 4.15% | Long | EC | |
| BioNTech SE | BNTX | 63,153 | $6,533,178 | 4.07% | Long | — | |
| EXELIXIS, INC. | EXEL | 137,027 | $6,092,220 | 3.80% | Long | EC | |
| Twist Bioscience Corp | TWST | 103,936 | $6,075,059 | 3.79% | Long | EC | |
| REGENERON PHARMACEUTICALS, INC. | REGN | 8,462 | $5,983,142 | 3.73% | Long | EC | |
| VERTEX PHARMACEUTICALS INCORPORATED | VRTX | 13,345 | $5,703,386 | 3.55% | Long | EC | |
| INCYTE CORPORATION | INCY | 59,291 | $5,648,654 | 3.52% | Long | EC | |
| IDEAYA Biosciences Inc | IDYA | 149,434 | $4,348,529 | 2.71% | Long | EC | |
| Immunitybio Inc | IBRX | 589,940 | $4,188,574 | 2.61% | Long | EC | |
| CARIS LIFE SCIENCES, INC. | CAI | 205,671 | $3,907,749 | 2.44% | Long | EC | |
| ARCUS BIOSCIENCES, INC. | RCUS | 133,599 | $3,406,775 | 2.12% | Long | EC | |
| CRISPR Therapeutics AG | CRSP | 55,336 | $2,896,286 | 1.80% | Long | EC | |
| NOVAVAX, INC. | NVAX | 264,512 | $2,096,258 | 1.31% | Long | EC | |
| Iovance Biotherapeutics Inc | IOVA | 593,884 | $1,995,450 | 1.24% | Long | EC | |
| Nuvation Bio Inc | NUVB | 426,642 | $1,898,557 | 1.18% | Long | EC | |
| Vir Biotechnology Inc | VIR | 167,572 | $1,711,748 | 1.07% | Long | EC | |
| ABCELLERA BIOLOGICS INC. | ABCL | 411,289 | $1,706,849 | 1.06% | Long | EC | |
| Corvus Pharmaceuticals Inc | CRVS | 102,168 | $1,551,932 | 0.97% | Long | EC | |
| Janux Therapeutics Inc | JANX | 95,943 | $1,378,701 | 0.86% | Long | EC | |
| Kura Oncology Inc | KURA | 150,470 | $1,328,650 | 0.83% | Long | EC | |
| CytomX Therapeutics Inc | CTMX | 228,039 | $962,325 | 0.60% | Long | EC | |
| Ocugen Inc | OCGN | 548,690 | $949,234 | 0.59% | Long | EC | |
| RIGEL PHARMACEUTICALS, INC. | RIGL | 31,513 | $910,726 | 0.57% | Long | EC | |
| INTELLIA THERAPEUTICS, INC. | NTLA | 66,593 | $897,674 | 0.56% | Long | EC | |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | PACB | 483,024 | $768,008 | 0.48% | Long | EC | |
| Design Therapeutics Inc | DSGN | 55,761 | $758,350 | 0.47% | Long | EC | |
| Ginkgo Bioworks Holdings Inc | DNA | 75,293 | $636,979 | 0.40% | Long | EC | |
| VERASTEM, INC. | VSTM | 116,276 | $634,867 | 0.40% | Long | EC | |
| Alvotech SA | ALVO | 188,379 | $629,186 | 0.39% | Long | EC | |
| Personalis Inc | PSNL | 94,670 | $522,578 | 0.33% | Long | EC | |
| Xencor Inc | XNCR | 40,644 | $484,883 | 0.30% | Long | EC | |
| Prime Medicine Inc | PRME | 56,846 | $201,519 | 0.13% | Long | EC | |
| Mereo BioPharma Group PLC | MREO | 232,638 | $62,440 | 0.04% | Long | — |